Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-31

FDA Approved: POTASSIUM CITRATE — Supplemental Application (Camber Pharmaceuticals, Inc)

View source ↗

Summary

The FDA approved a supplemental application for Potassium citrate submitted by Camber Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • POTASSIUM CITRATE (Potassium citrate)

Snippet

SUPPL AP for POTASSIUM CITRATE (POTASSIUM CITRATE)